Invention Grant
- Patent Title: Predicting likelihood of response to combination therapy
-
Application No.: US14724732Application Date: 2015-05-28
-
Publication No.: US10253369B2Publication Date: 2019-04-09
- Inventor: Catherine Schnabel , Yi Zhang , Mark G. Erlander
- Applicant: BIOTHERANOSTICS, INC
- Applicant Address: US CA San Diego
- Assignee: BIOTHERANOSTICS, INC.
- Current Assignee: BIOTHERANOSTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Agent Wenhua Yu
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886
Abstract:
Provided are methods of determining whether a subject having ER+ breast cancer is expected to benefit from treatment with combination endocrine therapy and mTOR inhibitor therapy. Also provided are methods of treating a subject having ER+ breast cancer.
Public/Granted literature
- US20150344967A1 PREDICTING LIKELIHOOD OF RESPONSE TO COMBINATION THERAPY Public/Granted day:2015-12-03
Information query
